These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 26781175

  • 21. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
    Toriguchi K, Hatano E, Tanabe K, Takemoto K, Nakamura K, Koyama Y, Seo S, Taura K, Uemoto S.
    J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
    [Abstract] [Full Text] [Related]

  • 22. Cross talk between toll-like receptor-4 signaling and angiotensin-II in liver fibrosis development in the rat model of non-alcoholic steatohepatitis.
    Shirai Y, Yoshiji H, Noguchi R, Kaji K, Aihara Y, Douhara A, Moriya K, Namisaki T, Kawaratani H, Fukui H.
    J Gastroenterol Hepatol; 2013 Apr; 28(4):723-30. PubMed ID: 23301938
    [Abstract] [Full Text] [Related]

  • 23. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
    Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC.
    Hepatology; 2006 Apr; 43(4):826-36. PubMed ID: 16557554
    [Abstract] [Full Text] [Related]

  • 24. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice.
    Chen T, Zhong FJ, Hong YM, Su WJ, Zhuang LL, Qiu LX.
    Chin J Nat Med; 2014 Mar; 12(3):194-8. PubMed ID: 24702805
    [Abstract] [Full Text] [Related]

  • 25. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
    Rahman SM, Schroeder-Gloeckler JM, Janssen RC, Jiang H, Qadri I, Maclean KN, Friedman JE.
    Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
    [Abstract] [Full Text] [Related]

  • 26. Prevention of steatohepatitis by pioglitazone: implication of adiponectin-dependent inhibition of SREBP-1c and inflammation.
    Da Silva Morais A, Lebrun V, Abarca-Quinones J, Brichard S, Hue L, Guigas B, Viollet B, Leclercq IA.
    J Hepatol; 2009 Mar; 50(3):489-500. PubMed ID: 19155087
    [Abstract] [Full Text] [Related]

  • 27. Sesame oil attenuates nutritional fibrosing steatohepatitis by modulating matrix metalloproteinases-2, 9 and PPAR-γ.
    Periasamy S, Hsu DZ, Chang PC, Liu MY.
    J Nutr Biochem; 2014 Mar; 25(3):337-44. PubMed ID: 24445078
    [Abstract] [Full Text] [Related]

  • 28. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet.
    Koppe SW, Sahai A, Malladi P, Whitington PF, Green RM.
    J Hepatol; 2004 Oct; 41(4):592-8. PubMed ID: 15464239
    [Abstract] [Full Text] [Related]

  • 29. [The role of heme oxygenase-1 in non-alcoholic steatohepatitis].
    Wang RQ, Nan YM, Han F, Zhao SX, Fu N, Wu WJ.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):680-4. PubMed ID: 20943080
    [Abstract] [Full Text] [Related]

  • 30. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H, Kumagai N, Watanabe S, Toda K, Takeuchi O, Tsunematsu S, Morinaga S, Tsuchimoto K.
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
    [Abstract] [Full Text] [Related]

  • 31. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [Abstract] [Full Text] [Related]

  • 32. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
    Zhao JS, Zhu FS, Liu S, Yang CQ, Chen XM.
    Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
    [Abstract] [Full Text] [Related]

  • 33. Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy.
    Zou JN, Xiao J, Hu SS, Fu CS, Zhang XL, Zhang ZX, Lu YJ, Chen WJ, Ye ZB.
    Chin Med J (Engl); 2017 Apr 20; 130(8):906-913. PubMed ID: 28397719
    [Abstract] [Full Text] [Related]

  • 34. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K.
    Biochem Biophys Res Commun; 2004 Feb 27; 315(1):187-95. PubMed ID: 15013444
    [Abstract] [Full Text] [Related]

  • 35. PPARgamma is essential for protection against nonalcoholic steatohepatitis.
    Wu CW, Chu ES, Lam CN, Cheng AS, Lee CW, Wong VW, Sung JJ, Yu J.
    Gene Ther; 2010 Jun 27; 17(6):790-8. PubMed ID: 20376096
    [Abstract] [Full Text] [Related]

  • 36. Protective role of autophagy in methionine-choline deficient diet-induced advanced nonalcoholic steatohepatitis in mice.
    Chen R, Wang Q, Song S, Liu F, He B, Gao X.
    Eur J Pharmacol; 2016 Jan 05; 770():126-33. PubMed ID: 26593434
    [Abstract] [Full Text] [Related]

  • 37. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
    Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T, Hibi T.
    Hepatology; 2008 Aug 05; 48(2):458-73. PubMed ID: 18666257
    [Abstract] [Full Text] [Related]

  • 38. Shc inhibitor idebenone ameliorates liver injury and fibrosis in dietary NASH in mice.
    Jiang JX, Tomilov A, Montgomery C, Hui CK, Török NJ, Cortopassi G.
    J Biochem Mol Toxicol; 2021 Oct 05; 35(10):e22876. PubMed ID: 34369032
    [Abstract] [Full Text] [Related]

  • 39. Combination effects of alogliptin and pioglitazone on steatosis and hepatic fibrosis formation in a mouse model of non-alcoholic steatohepatitis.
    Amano Y, Tsuchiya S, Imai M, Tohyama K, Matsukawa J, Isono O, Yasuno H, Enya K, Koumura E, Nagabukuro H.
    Biochem Biophys Res Commun; 2018 Feb 26; 497(1):207-213. PubMed ID: 29428719
    [Abstract] [Full Text] [Related]

  • 40. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
    Li L, Chen L, Hu L, Liu Y, Sun HY, Tang J, Hou YJ, Chang YX, Tu QQ, Feng GS, Shen F, Wu MC, Wang HY.
    Hepatology; 2011 Nov 26; 54(5):1620-30. PubMed ID: 21809356
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.